ES8706455A1 - Un dispositivo medico para la administracion transdermica de un agente biologico - Google Patents

Un dispositivo medico para la administracion transdermica de un agente biologico

Info

Publication number
ES8706455A1
ES8706455A1 ES556380A ES556380A ES8706455A1 ES 8706455 A1 ES8706455 A1 ES 8706455A1 ES 556380 A ES556380 A ES 556380A ES 556380 A ES556380 A ES 556380A ES 8706455 A1 ES8706455 A1 ES 8706455A1
Authority
ES
Spain
Prior art keywords
fibres
bonded
orientated
randomly
reinforcing means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556380A
Other languages
English (en)
Other versions
ES556380A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES8706455A1 publication Critical patent/ES8706455A1/es
Publication of ES556380A0 publication Critical patent/ES556380A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DISPOSITIVO PARA LA ADMINISTRACION TRANSDERMICA DE UN AGENTE BIOLOGICO. COMPRENDE: UN RESERVORIO (2) PARA FACILITAR LA MANIPULACION, APLICACION Y RETIRADA DEL DISPOSITIVO Y COMUNICAR UN TACTO TEXTURADO A LA PORCION DISTAL DEL CUERPO DEL DISPOSITIVO (1), UTILIZANDOSE UN FORRO DESPRENDEDOR IMPERMEABLE (5), ADAPTADO PARA SER ARRANCADO DE LA SUPERFICIE DE CONTACTO CON EL CUERPO DEL RESERVORIO (2) DE DROGA ANTES DE SU USO, PARA PROTEGER EL SISTEMA EN SU ENVASE; Y UN ELEMENTO REFORZANTE (3) ADHERIDO AL DISPOSITIVO (1) EMBEBIDO EN LA SUPERFICIE SUPERIOR DEL RESERVORIO (2) FORMANDO UNA CAPA DISCRETA DE AGENTE ADHERENTE (4). TIENE APLICACIONES CLINICAS.
ES556380A 1986-01-13 1986-06-20 Un dispositivo medico para la administracion transdermica de un agente biologico Expired ES8706455A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/818,561 US4725439A (en) 1984-06-29 1986-01-13 Transdermal drug delivery device

Publications (2)

Publication Number Publication Date
ES8706455A1 true ES8706455A1 (es) 1987-07-01
ES556380A0 ES556380A0 (es) 1987-07-01

Family

ID=25225824

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556380A Expired ES8706455A1 (es) 1986-01-13 1986-06-20 Un dispositivo medico para la administracion transdermica de un agente biologico

Country Status (8)

Country Link
US (2) US4725439A (es)
EP (1) EP0232580B1 (es)
JP (1) JPH0811726B2 (es)
KR (1) KR930001081B1 (es)
CA (1) CA1257819A (es)
DE (1) DE3687067T2 (es)
ES (1) ES8706455A1 (es)
GB (1) GB2185187B (es)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent
US5032109A (en) * 1987-02-10 1991-07-16 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
DE3738620A1 (de) * 1987-11-13 1989-05-24 Luderschmidt Christoph Verwendung von ethisterone zur topischen behandlung von akne oder androgenetischer alopezie
US4906475A (en) 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
US4913957A (en) * 1988-05-23 1990-04-03 Kimberly-Clark Corporation Thermal retaining fabric laminate
IL92496A0 (en) * 1988-12-01 1990-08-31 Schering Corp Compositions for transdermal delivery of estradiol
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5246705A (en) * 1992-04-08 1993-09-21 Cygnus Therapeutic System Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
PT1382340E (pt) * 1993-01-19 2006-07-31 Endorech Inc Utilizacoes terapeuticas de desidroepiandrosterona para tratar libido diminuida e osteoporose
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US6086921A (en) 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
DE19546024C2 (de) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
US5736154A (en) * 1996-03-11 1998-04-07 Fuisz Technologies Ltd. Transdermal delivery system
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
US6174545B1 (en) 1997-07-01 2001-01-16 Alza Corporation Drug delivery devices and process of manufacture
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
CA2295595A1 (en) 1997-07-09 1999-01-21 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
CN1161164C (zh) * 1997-12-11 2004-08-11 阿尔扎有限公司 用于通过体表导入或提取质剂的装置
PT1037686E (pt) * 1997-12-11 2005-10-31 Alza Corp Aparelho para potenciar o fluxo de agente transdermico
DK1037687T3 (da) 1997-12-11 2009-01-26 Alza Corp Anordning til at forbedre et middels transdermale strömning
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
NZ536787A (en) 1998-06-11 2006-03-31 Endorech Inc Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta diol
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CA2335636A1 (en) * 1998-06-22 1999-12-29 Unihart Corporation Sticking plaster for controlled release of natural interferon
IL140475A0 (en) * 1998-06-25 2002-02-10 Lavipharm Lab Inc A device and method for the treatment of erectile dysfunction
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
DE19840191A1 (de) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Arzneistoffhaltiges Pflaster mit drei funktionalen Schichten
US6348210B1 (en) 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
GB2352971A (en) * 1999-06-11 2001-02-14 Bambour Olubukola Omoyiola Transdermal administration of pharmaceuticals in prostate cancer and genito-urinary treatment
WO2001041745A1 (en) 1999-12-10 2001-06-14 Lectec Corporation Anti pruritic patch
DE60024312T2 (de) 1999-12-10 2006-08-17 Alza Corp., Mountain View Transdermale Wirkstoffabgabe von makromolekularen Wirkstoffen und Vorrichtung hierfür
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
HRP20030510A2 (en) * 2000-12-22 2005-04-30 Dr. August Wolff Gmbh & Co. Arzneimittel Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
KR100904158B1 (ko) * 2001-03-16 2009-06-23 알자 코포레이션 펜타닐 투여용 경피성 패치
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
KR100433363B1 (ko) * 2002-04-15 2004-05-28 주식회사 동구제약 아시클로버함유 외용필름형성 하이드로겔 제제
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
TWM240831U (en) * 2003-10-14 2004-08-21 Yohonda Entpr Co Ltd Sticky-type bra with cloth surface
US20050271597A1 (en) * 2004-02-13 2005-12-08 Keith Alec D Prostate hypertrophy treatment composition and method
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
ATE551995T1 (de) 2004-10-21 2012-04-15 Durect Corp Transdermale abgabesysteme
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
EP2308480B1 (en) * 2005-09-23 2014-08-13 ALZA Corporation High Enhancer-Loading Polyacrylate Formulation for Transdermal Applications
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
RS52671B (sr) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja
KR20090100357A (ko) 2006-11-16 2009-09-23 이-테라퓨틱스 리미티드 다중-약물 내성 세균 감염의 치료를 위한 이미다졸
GB0712101D0 (en) 2007-06-22 2007-08-01 Therapeutics Ltd E Treatment of depression
GB0714226D0 (en) 2007-07-20 2007-08-29 Therapeutics Ltd E anti-bacterial combination therapy
MY154027A (en) * 2007-10-15 2015-04-30 Alza Corp Once-a-day replacement transdermal administration of fentanyl
GB0813211D0 (en) 2008-07-18 2008-08-27 E Therapeutics Plc Antibacterial combination therapy for the treatment of gram positive bacterial infections
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
GB0915877D0 (en) 2009-09-10 2009-10-14 E Therapeutics Plc Cancer cell apoptosis
SG186333A1 (en) 2010-06-16 2013-01-30 Endorech Inc Methods of treating or preventing estrogen-related diseases
DE102010031824A1 (de) 2010-07-20 2012-01-26 Trützschler Nonwovens Gmbh Vorrichtung zum Auftragen von fluiden Medien
GB201016995D0 (en) 2010-10-08 2010-11-24 Univ Dundee Cancer targets
GB201101793D0 (en) 2011-02-02 2011-03-16 Univ Edinburgh Weight related disorders
GB201207305D0 (en) 2012-04-26 2012-06-13 E Therapeutics Plc Therapy
GB201207907D0 (en) 2012-05-04 2012-06-20 E Therapeutics Plc Treatment of depression
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
CA2964000A1 (en) 2014-10-21 2016-04-28 The Procter & Gamble Company Kit for improving skin appearance
US10576023B2 (en) * 2015-10-22 2020-03-03 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US9872816B2 (en) 2015-10-22 2018-01-23 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017068349A1 (en) 2015-10-23 2017-04-27 E-Therapeutics Plc Cannabinoid for use in immunotherapy
US10806681B2 (en) 2017-01-09 2020-10-20 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
EP3641952B1 (en) 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
CN111698984B (zh) 2018-03-19 2023-11-14 宝洁公司 制备具有可溶性膜的阻隔贴片的方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
US3813466A (en) * 1964-01-08 1974-05-28 Parachem Corp Wound dressings
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
GB1594389A (en) * 1977-06-03 1981-07-30 Max Planck Gesellschaft Dressing material for wounds
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
US4164045A (en) * 1977-08-03 1979-08-14 Carbomedics, Inc. Artificial vascular and patch grafts
US4307717A (en) * 1977-11-07 1981-12-29 Lectec Corporation Sterile improved bandage containing a medicament
GB2030860B (en) * 1978-02-20 1982-08-18 Bates W Surgical dressings
US4243656A (en) * 1978-05-19 1981-01-06 Walliczek Erwin G Biosynthetic polymeric compositions
JPS5699410A (en) * 1980-01-10 1981-08-10 Japan Vilene Co Ltd Plaster
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS5843368B2 (ja) * 1980-10-30 1983-09-27 日東電工株式会社 消炎鎮痛貼付剤
EP0056702B1 (en) * 1981-01-21 1985-07-03 Imperial Chemical Industries Plc Process of producing fibre-reinforced shaped articles
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
GB2120946B (en) * 1982-06-02 1985-11-06 Ethicon Inc Improvements in synthetic vascular grafts
JPS5936608A (ja) * 1982-08-23 1984-02-28 Hisamitsu Pharmaceut Co Inc 新規貼付薬
JPS6066758A (ja) * 1983-09-21 1985-04-16 日東電工株式会社 医薬製剤
CA1238152A (en) * 1983-11-04 1988-06-21 Howmet Turbine Components Corporation Anisotropic surgical prosthesis
US4704282A (en) * 1984-06-29 1987-11-03 Alza Corporation Transdermal therapeutic system having improved delivery characteristics
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
JP2551318B2 (ja) * 1992-04-10 1996-11-06 株式会社ニッショー 輸液用容器
JPH0675428A (ja) * 1992-08-26 1994-03-18 Fuji Xerox Co Ltd 磁性粉含有微粒子の製造方法
JPH06333325A (ja) * 1993-05-24 1994-12-02 Fujitsu Ltd ディスク装置

Also Published As

Publication number Publication date
US4725439A (en) 1988-02-16
GB2185187A (en) 1987-07-15
EP0232580B1 (en) 1992-11-04
US4867982A (en) 1989-09-19
GB8615106D0 (en) 1986-07-23
EP0232580A2 (en) 1987-08-19
GB2185187B (en) 1989-10-25
JPS62167724A (ja) 1987-07-24
EP0232580A3 (en) 1989-06-21
DE3687067T2 (de) 1993-05-06
KR930001081B1 (ko) 1993-02-15
ES556380A0 (es) 1987-07-01
KR870006906A (ko) 1987-08-13
DE3687067D1 (de) 1992-12-10
JPH0811726B2 (ja) 1996-02-07
CA1257819A (en) 1989-07-25

Similar Documents

Publication Publication Date Title
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
NZ220016A (en) Transdermal drug delivery system with drug reservoir(s), adhesive layer(s) and flexible backing layer
DE59803647D1 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
EP0307187A3 (en) Adhesive dressings containing a pharmaceutically active ingredient
IE872291L (en) Transdermal therapeutic system
KR870006906A (ko) 피부투과식 약물투여장치
ZA200210340B (en) Anchoring system for luer lock connector.
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
CA2272381A1 (en) Adhesive composition comprising a polysiloxane
NL970007I1 (nl) Transdermaal oestradiotoedieningssysteem.
DE59103721D1 (de) Wundauflagensystem.
AU762853B2 (en) Self-adhesive bandage
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
ES8704740A1 (es) Procedimiento para preparar un producto farmaceutico para la entrega controlada de sustancias activas a la piel,preferentemente en forma de un emplasto
EP0343807A3 (en) Absorptive adhesive dressing with controlled hydration
ATE226833T1 (de) Trägermaterial für medizinische zwecke
AU4739089A (en) Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
HU0000045D0 (en) Thin adhesive plaster treated by betamethasone- and hyaluronic acid- for treatment of psoriasis, dermatitis and dermatosis
AR003979A1 (es) Administracion transdermica de vorozol.
CN2481311Y (zh) 一种伤口包扎条
CA2170289A1 (en) A method of treating liver disease and like indications with vasodilating agents
CA2339814A1 (en) Anchoring system for a catheter or the like
CN86204205U (zh) 伤口愈合带

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070514